NEW
YORK, July 19, 2023 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of Bausch
Health Companies Inc.:
The investigation focuses on whether Bausch Health issued false
and/or misleading statements and/or failed to disclose information
pertinent to investors concerning its 2022 earnings and guidance
and its patent dispute over Xifaxan. On May
10, 2022, Bausch Health announced its first-quarter 2022
results, prompting the stock price to fall $3.50 per share. Analysts attributed the decline
to concerns around the Company's spin-off of Bausch + Lomb
Corporation, high debt levels, and anticipation over the Xifaxan
patent decision. On July 28, 2022,
the Company issued an update on the Xifaxan patent dispute case
between Bausch Health and Norwich.
In response to this news, market analysts downgraded Bausch Health
and its stock price fell an additional $3.58 per share, representing a decline of more
than 50% from its trading price just two months earlier.
Due to the forgoing, The Gross Law Firm is investigating
potential securities fraud claims on behalf of certain
Bausch Health investors. If you incurred a loss on your BHC
investment, please contact us using the link below to discuss your
rights.
https://securitiesclasslaw.com/securities/bausch-health-loss-submission-form/?id=42276&from=4
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law
Firm is committed to ensuring that companies adhere to responsible
business practices and engage in good corporate citizenship. The
firm seeks recovery on behalf of investors who incurred losses when
false and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original
content:https://www.prnewswire.com/news-releases/investigation-alert-the-gross-law-firm-notifies-shareholders-of-bausch-health-companies-inc-of-an-investigation-and-potential-class-action-lawsuit--nyse-bhc-301880307.html
SOURCE The Gross Law Firm